About
Ncardia provides human iPSC-based products, assays, and custom services for drug discovery, disease modeling, toxicology, safety pharmacology, and regenerative medicine. It serves biopharmaceutical and research customers working on small molecules, RNA therapies, gene therapies, and biologics from sites in Europe and North America.
Services
iPSC products
Provides ready-to-use human iPSC-derived cell models manufactured to scale and available for cardiovascular, neural, vascular, and smooth muscle applications.
Custom iPSC reprogramming
Reprograms selected starting material into iPSCs for customer-specific research needs.
Custom iPSC differentiation
Differentiates iPSCs into functional cell types at the scale needed for screening, preclinical cell therapy, and tissue or organ engineering.
iPSC gene editing
Performs knock-out and knock-in editing using STAR-CRISPR technology.
iPSC-based assays
Develops iPSC-based assays for pilot studies, validation studies, and full screening campaigns.
Ready-to-use assays
Offers standardized iPSC-based screening assays for efficacy and safety studies.
Custom screening services
Develops disease-relevant screening assays and custom screening workflows tailored to specific research questions.
Drug discovery services
Supports target identification, hit finding, lead optimization, and preclinical candidate selection using iPSC-based models.
11 more services
- Disease modeling
- Toxicology and safety pharmacology
- IO Safety Panel
- Small molecule screening platform
- RNA therapeutics screening platform
- Gene therapy screening platform
- Biologics discovery platform
- iPSC Reprogramming
- iPSC Differentiation
- Custom Screening Applications
- Custom iPSC Cell Services
- What to send
- Preferred starting material for reprogramming
- Tissue or cell samples for patient- or disease-specific model creation
- Customer's own iPSC lines
- Starting material for iPSC reprogramming
- Your own iPSC lines
- Tissue or cell samples for custom models
Capabilities
- Assays and studies
- Toxicology
- Non-human primate
- Small molecules
- HTS
- Cell therapy
- CRISPR
24 more
- High-content imaging
- Flow cytometry
- qPCR
- Patch clamp
- Efficacy screening
- Safety screening
- Cardiotoxicity
- Neurotoxicity
- Cardiac hypertrophy
- Gene modulation
- Endothelial barrier function
- 3D cardiac microtissues
- Cell viability
- Cell morphology
- Gene expression
- Protein expression
- Biomarker detection
- Electrophysiological activity
- Organelle characterization
- Monoculture
- Co-culture
- Triculture
- 2D formats
- 3D formats
- Scale and capacity
- Manufactured to scale
- High-throughput screening campaigns
- High-throughput production of genetically defined iPSC lines
- Large-scale batches
- Therapeutic areas
- Drug discovery
- Disease modeling
- Regenerative medicine
- Toxicology
- Safety pharmacology
- Neuroscience
13 more
- Cardiac
- Immune-oncology
- Renal
- Liver
- Fibrosis
- Cardiovascular
- Neurological disorders
- Parkinson's disease
- Alzheimer's disease
- ALS / FTD
- Neuroinflammation
- Cardiac hypertrophy
- Endothelial barrier function
Instruments and platforms
- High Content Imaging
- Incucyte
- ImageXpress Confocal
- xCELLigence RTCA Cardio
- CardioExcyte 96
- Cytation
14 more
- BioRad Opus 384 qPCR
- RNAseq
- Whole genome sequencing
- Spark Multimode Microplate Reader
- NovoCyte Flow Cytometer
- Maestro MEA
- LUMO
- Automation for HTS
- Multi-Electrode Array (MEA)
- FDSS - Calcium Imaging
- Mesoscale Discovery Platform (MSD)
- FACS
- Plate Readers
- qPCR
Modalities and species
- Modalities
- Small molecule
- Antibody
- Oligonucleotide
- mRNA
- Cell therapy
- Gene editing
- Recombinant protein
- Species and models
- Human iPSC-derived cells
- Ncyte® vCardiomyocytes
- Ncyte® aCardiomyocytes
- Ncyte® Endothelial Cells
- Ncyte® Astrocytes
- Ncyte® Microglia
14 more
- Ncyte® GABAergic Neurons
- Ncyte® Excitatory Neurons
- Ncyte® Cholinergic Neurons
- Ncyte® Motor Neurons
- Ncyte® Dopaminergic Neurons
- Ncyte® Sensory Neurons
- Ncyte® Smooth Muscle Cells
- NHP C vCardiomyocytes
- Patient-derived iPSC lines
- hiPSC-microglia
- hiPSC-derived motor neurons
- hiPSC-derived neurons
- hiPSC-derived cardiomyocytes
- hiPSC-derived astrocytes
Details
- Type
- CRO
- Quality
- Rigorous quality control (cell models and assays) · robust QA assays (identity, activity, and phenotypic relevance) · controlled conditions (iPSC-derived tissues in IO Safety Panel) · STAR-CRISPR (proprietary gene editing technology)
- Address
- Oortweg 21 2333 CH Leiden 2333 BD Leiden The Netherlands item.aria_lab
- Serves
- Europe, North America, worldwide
Public records
- Parent company
- Ncardia AG · DE GLEIF